Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Biota to sue GlaxoSmithKline over Relenza flu drug

Biotech Biota Holdings is suing global pharmaceutical giant GlaxoSmithKline, alleging that GSK failed to support and promote Biota's flu drug, Relenza.

Upgrade your subscription to access this article

And gain access to:
  • All archived news content
  • Access to the Financial Standard app
  • Home page news customisation
  • Financial Standard 's fortnightly newspaper
  • 25% discount on tickets to networking events
And more
Already A Subscriber?